Abstract : The discovery of the neurogenesis, migration and differentiation of neural stem cells in experimental models of stroke reveals a potential new facet of recovery after stroke that may translate into new treatments for stroke and other neurological disorders. New neurons are regenerated and functional recovery is enhanced with neural stem cell transplantation in stroke. In this review, we summarize the recent experiences about intravenous transplantation of human neural stem cells in various stroke models.
could integrate in the ischemic brain, and reduce the neurological deficits induced by experimental brain ischemia. It has long been thought that the capacity for intrinsic repair after adult mammalian central nervous system (CNS) injury is limited because the mature CNS, with rare exception, can neither generate new neuron. The limited ability of the mature CNS to generate new cellular elements limits the selfrepair capacity of the damaged brain. Neural stem cells (NSCs) are primordial, uncommitted cells postulated to give rise to the array of more specialized cells of the CNS. They are operationally defined by their ability (1) to differentiate into cells of all neural lineages (i.e., neurons, oligodendroglia, astroglia) ; (2) to self-renew (to give rise to new NSCs with similar potential) ; and (3) to populate developing and/or degenerating CNS regions. The demonstration of a monoclonal derivation of progeny is obligatory to the definition (i.e., a single cell must possess these attributes). With the earliest recognition that rodent neural cells with stem cell properties, propagated in culture, could be re-implanted into mammalian brain where they could reintegrate appropriately and stably express foreign genes, gene therapists and neurobiologists began to speculate how such a phenomenon might be harnessed for therapeutic advantage as well as for understanding developmental mechanisms.
NSCs persist in the subventricular zone (SVZ), hip- 
Global forebrain ischemia
Global forebrain ischemia models mimic the hypoxic-ischemic injury (consequences of cardiac arrest or coronary artery occlusion) in humans, and cause selective pyramidal neuronal loss in CAI of hippocampus, leading to memory loss.
Global forebrain ischemia gives rise to enhanced cell proliferation in the rodent subgranular layer (SGL) of dentate gyrus (DG) . 
Focal cerebral ischemia
Stroke induced by middle cerebral artery occlusion (MCAO) leads to increased cell proliferation and increased numbers of immature neurons in the ipsilateral subventricular zone (SVZ). At 2 weeks after the insult, many neuroblasts migrate to the damaged striatal area, with expression of Meis2 and Pbx proteins, which are normally co-localized within developing striatal medium-sized spiny neurons". However, only a small fraction of the dead striatal neurons (about 0.2%) is replaced by the new neurons (DARP 32'cells) after stroke").
In our study, the i.v.-injected human NSCs migrate to the damaged areas, differentiate into cortical or striatal neurons and astrocytes, and induced functional recovery without immune suppression (Chu K et al., unpublished data) . The migratory pattern is similar to that in global forebrain ischemia. These cells are found as long as 540 days after transplantation, without causing neoplasm and complications.
Intracerebral hemorrhage
The evidences of endogenous neurogenesis after intracerebral hemorrhage Q CH) have not been reported. The neurological deficits caused by ICH may be explained by several mechanisms ; mass effect of newly formed hematoma, perihematomal cell death (apoptosis), perihematomal penumbra by spreading depression and edema, and inflammation. The harmful role of perihematomal apoptosis is recently highlighted, which may cause the permanent neurological deficit in ICH.
We transplanted five million human NSCs (HB 1. 
